You are here:Home-Chemical Inhibitors & Agonists-Others-Other Targets-DS55980254
DS55980254

Chemical Structure : DS55980254

CAS No.: 2488609-41-0

DS55980254 (DS 55980254)

Catalog No.: PC-49548Not For Human Use, Lab Use Only.

DS55980254 (DS 55980254) is potent, selective and orally active PTDSS1 (phosphatidylserine synthetase 1) inhibitor, suppresses phosphatidylserine (PS) production activity of PTDSS1 (IC50=100 nM) in cell-free assays, but not that of PTDSS2.

Packing Price Stock Quantity
2 mg $358 In stock
5 mg $498 In stock
10 mg $728 In stock
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

DS55980254 (DS 55980254) is potent, selective and orally active PTDSS1 (phosphatidylserine synthetase 1) inhibitor, suppresses phosphatidylserine (PS) production activity of PTDSS1 (IC50=100 nM) in cell-free assays, but not that of PTDSS2.
DS55980254 strongly suppressed the de novo PS synthesis in PTDSS2-KO HCT116 clone, whereas they weakly suppressed it in parental HCT116.
DS55980254 selectively suppressed the growth of PTDSS2-KO HCT116 in vitro.(
DS55980254 (10-30 mg/kg, daily, p.o.) induced tumor regression in PTDSS2-KO HCT116 and PTDSS2-KO A375 subcutaneous xenograft models, without body weight loss and severe toxicity.
DS55980254 induced selective cell death in PTDSS2-deleted cancer cells, induced ER stress downstream of PS depletion in PTDSS2-deleted tumor cells.
DS55980254 suppressed the growth of tumor containing both PTDSS2 wild-type and knockout cells in immunocompetent mice, showing potency for overcoming tumor heterogeneity by modulating the tumor immune microenvironment.

Physicochemical Properties

M.Wt 638.46
Formula C29H18F8N4O4
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

7-(4-(4-(3,5-bis(trifluoromethyl)phenoxy)phenyl)-5-(2,2-difluoropropyl)-6-oxo-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)benzo[d]oxazol-2(3H)-one

References

1. Yohei Yoshihama, et al. Cancer Res. 2022 Nov 2;82(21):4031-4043.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: